Seattle scientists make progress on cure for genital herpes
Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”
Bird flu virus isolated from hospitalized Canadian teen shows signs of human adaptation
Dr. Jesse Bloom commented on viral mutations found in a case of H5N1. He said, “It’s caught the attention of a lot of flu virologists, including myself, because some of the sequence has evidence of some of the types of mutations we worry about.”
COVID vaccine update: CDC now recommends second dose for older adults, immunocompromised
Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”
Meet the 2024 STAT Wunderkinds
STAT included Miguel Paredes in the Bedford Lab and Yapeng Su in the Greenberg Lab in its Wunkerkinds awards to 27 of the “most impressive doctors and researchers on the cusp of launching their careers.”
A viral gene drive could offer a new approach to fighting herpes
Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”
What does it mean to be immunocompromised?
Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”
Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay
Dr. Jesse Bloom explained how virus mutations could change the accuracy of serology tests for infections: "This type of mutation could make you want to then redo the assays with a virus that contained that mutation.”
These four common infections can cause cancer
Drs. Denise Galloway and Nina Salama discussed how HPV and H. Pylori can cause cancer. Galloway said, “If you vaccinate someone who’s young, the risk goes down to zero.”
FDA authorizes updated COVID vaccines. Who should get the shot and when, according to experts
Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
AIDS crisis from 1980s to today: How Seattle responded with hope, healing
Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”
Herpes cure on the horizon
Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”
Seattle virologists find promising new results for potential herpes cure
Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”
There’s bird flu RNA in grocery store milk. How sequncing it might help fight avian influenza
Dr. Pavitra Roychoudhury described how researchers sequenced a bird flu genome from store-bought milk, noting that “this is, to our knowledge, the first time it’s been done in commercially available milk, to obtain the full genome.”
Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows
Dr. Trevor Bedford noted that “separate from the sequencing for evolution [of the virus], which I think is very important, just even understanding prevalence through space and time... would be really helpful and important.”
The new horizon of HIV vaccines
Louis Shackleford emphasized that “the prospect of having a vaccine that can last for years and give us sustained protection from HIV would be an amazing boon for communities such as the Black community who disproportionately are suffering from HIV.”
A new type of bacteria was found in 50% of colon cancers. Many were aggressive cases.
Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.
After decades of failures, researchers have renewed hopes for an effective HIV vaccine
Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”
Dr. Jim Boonyaratanakornkit discusses respiratory illnesses
Dr. Jim Boonyaratanakornkit encouraged people to get vaccinated for COVID, flu and RSV.
Can these drugs stop a COVID infection in its tracks? Seattle researchers are on the forefront of new treatments
Dr. Liz Duke explained a study of antivirals to prevent COVID.
There’s still no HIV vaccine. The science behind coronavirus vaccines may help
Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.
New area eligibility for high-demand COVID-19 prevention drug
Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.
COVID cases are up. Most mandates ended months ago. So where does WA stand?
Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.
What’s next? How the COVID-19 pandemic is likely to look over the next few months
Dr. Rachel Bender Ignacio advocated for expanded access to COVID antivirals.
COVID hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
A STAT special report noted Dr. Trevor Bedford’s COVID predictions.
As COVID rates rise in Europe and Asia, how worried should Americans be about another wave?
Dr. Josh Schiffer reflected on the evolving nature of the pandemic.
As virus data mounts, the J&J vaccine holds its own
Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.
What health experts say about the ‘natural experiment’ of ditching mask mandates in WA
Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.
As COVID-19 cases fall, experts are optimistic, but for how long?
Dr. Elizabeth Halloran shared her thoughts on COVID-19 outlook in the U.S.
Project underway at Fred Hutch to bring more diversity to clinical trials
Drs. Michele Andrasik and Stephaun Wallace discussed diversity in vaccine trials.
COVID predictions? These experts are done with them
Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.
COVID antiviral pills work against omicron– when people can get them
Dr. Elizabeth Duke explained how COVID antivirals work.
After omicron, some scientists foresee a period of quiet
Dr. Trevor Bedford shared predictions about omicron.
Could Genomic Surveillance Prevent The Next Pandemic?
Dr. Trevor Bedford discussed the Seattle Flu Study and tracking viruses in a Bloomberg mini-documentary on genomic surveillance.
Halting progress and happy progress: How mRNA vaccines were made
Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.
Omicron is spreading at lightning speed. Scientists are trying to figure out why
Dr. Josh Schiffer compared omicron to previous variants.
Healthy, boosted people unlikely to develop severe omicron infections, but jury’s out on older, at-risk populations
Dr. Larry Corey highlighted the strain on hospital systems.
How contagious is omicron? What does that mean for you?
Dr. Josh Schiffer characterized recent COVID variants.
A computational biologist weighs in on omicron, the future of vaccines and the CDC’s variant forecast
Dr. Trevor Bedford shared insights in a Q&A, including updating COVID vaccines to circulating variants.
Gauteng’s Omicron Wave Is Already Peaking. Why?
In a Q&A, Dr. Trevor Bedford discussed the rapid rise of omicron and challenges in detecting cases.
Omicron surge predicted to peak higher than delta wave in King County: ‘It’s here and it’s moving fast'
Dr. Trevor Bedford joined a press briefing on omicron.
How the little-known B and T cells can protect against COVID variants
Dr. Jennifer Lund explained the immune response to COVID.
A Guide to Mixed-Vaccination-Status Holidays
Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.
Preparing for the Omicron Wave (with Trevor Bedford)
Dr. Trevor Bedford and Andy Slavitt discussed omicron.
Scientists in Washington researching COVID-19 Omicron variant to help protect public
Dr. Josh Schiffer described his concerns about omicron infections.
How did omicron mutate, and how could it evade antibodies? Fred Hutch scientist Trevor Bedford answers our questions
In an omicron-focused Q&A, Dr. Trevor Bedford mentioned how to prevent future variants.
Why Didn’t the U.S. Detect Omicron Cases Sooner?
Dr. Trevor Bedford commented on genomic surveillance of SARS-CoV-2.
Dr. Larry Corey on the Omicron variant of COVID
Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.
Omicron’s Best- and Worst-Case Scenarios
Dr. Elizabeth Halloran talked about implications of the latest COVID-19 variant.
The mystery of where omicron came from — and why it matters
Dr. Trevor Bedford discussed omicron’s evolutionary path.
Mysteries of omicron variant could take weeks to untangle
Dr. Trevor Bedford discussed early reports of spread of the omicron variant.
COVID-19 experts answer questions about Omicron -- and where the variant may have come from
Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.
The Omicron variant might have originated in someone with a suppressed immune system
Dr. Trevor Bedford explained how omicron differs from other gradually evolving strains of SARS-CoV-2.
U.S. tracking of virus variants has improved after a slow start
Dr. Trevor Bedford spoke on sequencing of variants.
How bad will omicron be? Scientists won’t really know for months
Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.
A different type of COVID vaccine is about to roll around the world
Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.
Treatments will change the pandemic, but they can’t end it alone
Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.
The pandemic’s next turn hinges on three unknowns
Dr. Elizabeth Halloran commented on COVID-19 immunity in the U.S.
COVID-19 Virus to Keep Mutating, but at Slower Rate, Expert Predicts
Dr. Trevor Bedford’s recent Twitter thread on how SARS-CoV-2 might continue to evolve was featured.
COVID vaccines were rolled out 10 months ago in Washington state. Where do we stand now?
Dr. Larry Corey commented on measures enacted to fight COVID-19.
FDA clears first coronavirus vaccine for 5- to 11-year-olds
Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.
Local doctors say children 5-11 years old could get vaccine by Thanksgiving
Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine.
Can New Variants of the Coronavirus Keep Emerging?
Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.
What to know about your risk of a serious or fatal breakthrough COVID infection
Dr. Rachel Bender Ignacio provided perspective on breakthrough COVID infections.
Why COVID boosters weren’t tweaked to better match variants
Dr. Trevor Bedford advocated for updating COVID vaccines against the Delta variant.
Yes, We’re Still Talking about Covid Vaccine Myths
Dr. Larry Corey underscored the safety of COVID vaccines.
Is There Another Reason Biden Likes Boosters?
Dr. Larry Corey commented on COVID vaccine boosters.
Merck COVID drug studied at Fred Hutch
Dr. Rachel Bender Ingacio characterized clinical trial results for molnupiravir.
Merck Says It Has the First Antiviral Pill Found to Be Effective Against Covid
Dr. Elizabeth Duke explained the potential of molnupiravir.
Fred Hutch’s Trevor Bedford receives ‘genius grant’ for work on COVID-19 and other viruses
Dr. Trevor Bedford commented on being named a 2021 MacArthur Fellow.
Trevor Bedford: Two astounding awards for virologist who raised early COVID alarms
Dr. Trevor Bedford reflected on receiving recognition for his research on viral evolution.
A daily pill to treat COVID could be just months away, scientists say
Dr. Elizabeth Duke spoke about the promise of an oral antiviral to treat and even prevent COVID.
These three Seattle scientists study the coronavirus. Now they’re getting millions to chase their ‘wildest scientific ideas’
Drs. Erick Matsen and Trevor Bedford were named Howard Hughes Medical Institute investigators.
Remdesivir Averts Hospitalization in Study of High-Risk Patients
Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:
Winter is coming, again: What to expect from Covid-19 as the season looms
Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.
COVID vaccine immunity is waning — how much does that matter?
Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.
Long-haul COVID-19 can last months. But here’s why experts are optimistic about recovery.
Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.
Analysis: U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Covid-19 Virus Variants Mu and Lambda Unlikely to Supplant Delta
Dr. Trevor Bedford characterized the landscape of COVID variants.
United States boosts tracking of coronavirus strains as Mu variant draws scrutiny
Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.
Johnson & Johnson’s HIV vaccine fails first efficacy trial
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Many patients with cancer lack adequate immunity to measles, mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
New Evidence Points To Antibodies As A Reliable Indicator Of Vaccine Protection
Dr. Holly Janes spoke with NPR.
Q&A: Seattle COVID-19 vaccine expert answers questions about booster shots
Dr. Larry Corey discussed COVID vaccine boosters.
As Delta Surges, Covid-19 Breakthrough Cases Remain Uncommon
Dr. Larry Corey discussed breakthrough cases of COVID.
Why a fast-spreading coronavirus and a half-vaccinated public can be a recipe for disaster
Dr. Josh Schiffer discussed the rise of variants.
Patients With Cancer May Have an Increased Risk for Measles and Mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Many People With Cancer Lack Protection Against Measles and Mumps
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
Study showing antibody levels protecting against COVID-19 could speed creation of new vaccines, boosters
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Antibody levels predictive of Moderna's vaccine efficacy -study
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Scientists may have found a marker of how effective COVID-19 vaccines are
Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.
Will COVID vaccine booster shots be needed? It's likely, experts say, but the immunocompromised should be prioritized.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
‘Goldilocks virus’: Delta vanquishes all variant rivals as scientists race to understand its tricks
Dr. Trevor Bedford commented on the delta variant with The Washington Post.
There Are Few Good COVID Antivirals, but That Could Be Changing
Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
Covid’s Lambda variant: worth watching, but no cause for alarm
Dr. Trevor Bedford described the newly emerged Lambda variant.
12 lessons COVID-19 taught us about developing vaccines during a pandemic
Dr. Larry Corey shared his reflections on the COVID vaccine program.
Vaccine Hesitancy or Systemic Racism?
Dr. Stephaun Wallace and co-authors wrote an op-ed on the misperceptions around vaccine hesitancy.
Study testing Moderna vaccine in transmission prevention to include young adults
Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.
Two reasons why doctors say anyone who's had COVID still needs to get poked
Dr. Stephaun Wallace explained why people who previously had COVID-19 still need to get vaccinated.
One year or five? Doctors and drug companies increasingly disagree about when we'll need COVID-19 booster shots
Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”
Stephaun Wallace on Seattle Gay News' inaugural podcast
In Seattle Gay News’ inaugural podcast, Dr. Stephaun Wallace discussed COVID and HIV vaccine research and engaging communities in science. He said, “One of the things I really appreciate about science is that you’re always learning something.”
A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots
Dr. Trevor Bedford reacted to speculation that a clade of the influenza virus may have gone extinct during the pandemic. He said, “I think it has a decent chance that it’s gone. But the world’s a big place.”
Who really needs coronavirus herd immunity? People with weakened immune systems
Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”
As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance
Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.
Finding how much protection is enough when it comes to COVID-19 vaccines
Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."
A Kent church is closing the vaccine equity gap, sometimes to a round of applause
Dr. Michele Andrasik commented on building vaccine confidence.
Masks and social distancing may still be needed for people with compromised immunity
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
The race to avoid a possible "monster" COVID variant
Dr. Josh Schiffer stressed rapid vaccination.
A vaccine without needles? It’s on the way
Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.
College Students Are Helping Answer Key Vaccine Questions, but Finding Enough of Them Is Tough
Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.
Meet the Seattle doctor who Dr. Fauci trusted to help develop COVID-19 vaccines
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
New Blood Tests Should Show How Long A COVID-19 Vaccine Will Protect You
Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.
Scientists Are Working On Booster Shots In Case COVID-19 Vaccines Lose Their Effect
Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.
What the Recent HIV Vaccine Research Findings Really Mean
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
Behind the mask: Public health innovator Dr. Stephaun Wallace
Dr. Stephaun Wallace reflected on his career in public health.
A vaccine study in college students will help determine when it’s safe to take masks off
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
You got vaccinated. Now what? 7 things to know for your post-COVID vaccine behavior
Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.
Meet an epidemiologist fighting to make vaccines work for communities of color
Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.
NCCN Guidelines Urge Patients With Cancer to Get a COVID-19 Vaccine, Whichever is Available
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Luck is essential for any successful coronavirus variant, study shows
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Unlocking the COVID code
Dr. Trevor Bedford commented on advances in the viral genomics field.
Do COVID-19 vaccines stop transmission? Top scientists are now recruiting thousands of college students to find out
Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.
Disappointment and Hope From Two HIV Prevention Trials
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
‘On your toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
In a Q&A, Dr. Josh Hill discussed treating infections in people receiving CAR T-cell therapy.
COVID-19 precautions shut down flu this season, but what will next winter bring?
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
Did Washington Get Its Vaccine Line Right?
Dr. Laura Matrajt discussed her mathematical models of COVID-19 vaccine distribution.
‘Then the world caved in’: 11 experts describe the day they realized Covid-19 was here to stay
STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.
We may never reach herd immunity on coronavirus — but it probably doesn’t matter
Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.
Worried About Coronavirus Variants? Here's What You Need To Know
Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..
The Coronavirus Is Plotting a Comeback. Here’s Our Chance to Stop It for Good.
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Washington high schools return to play knowing the COVID-19 risks, but hopeful about safety protocols
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.
People of color are underrepresented in US vaccine trials, study finds
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
C.D.C. Announces $200 Million ‘Down Payment’ to Track Virus Variants
Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.
Drugmakers Look for New Ways to Test Covid-19 Vaccines
Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.
The coronavirus is going to stick around forever. Get ready for the new normal.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
Covid masks save lives. The CDC says double-masking may save more.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report ‘minimal’ protection against coronavirus variant
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
With COVID-19 vaccine in short supply, scramble is on for second shots
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Mutated virus may reinfect people already stricken once with covid-19, sparking debate and concerns
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
If I have cancer, dementia or MS, should I get the Covid vaccine?
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
For the first time, researchers say infusions of antibodies can prevent HIV infection
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
Why vaccines alone will not end the pandemic
Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.
New strains of COVID swiftly moving through the US need careful watch, scientists say
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Are new coronavirus variants already in Washington state? With limited surveillance it’s hard to know
Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.
C.D.C. Warns the New Virus Variant Could Fuel Huge Spikes in Covid-19 Cases
Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”
New stem cell study provides clues for treatments that could eliminate HIV in infected patients
Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.
Math Can Help In Deciding How To Distribute The Vaccine
Dr. Laura Matrajt discussed her computer model that showed the benefit of administering one-dose vaccines to end the pandemic.
Fred Hutch seeks volunteers with COVID-19 to join tests of therapies
Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.
Where Year Two of the Pandemic Will Take Us
Dr. Jesse Bloom cautioned not to overly concerned about a new coronavirus strain and how dangerous it could be.
Cancer clinics confident in COVID-19 precautions to protect patients, survivors
Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.
Can vaccinated people still transmit COVID-19? The answer is key for herd immunity, research finds
Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.
The Coronavirus Is Mutating. What Does That Mean for Us?
Drs. Jesse Bloom and Trevor Bedford discussed implications of SARS-CoV-2 mutating.
FDA review clears path for second coronavirus vaccine, this one developed by Moderna
Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.
'It's history making:' Moderna's COVID-19 vaccine could be released this week
Dr. Jim Kublin reflected on progress in developing COVID-19 vaccines:
Black volunteers give COVID-19 vaccine trials a shot in the arm
Drs. Michele Andrasik and Adrienne Shapiro emphasized the disproportionate impact of COVID-19 on communities of color.
Q&A with Dr. Larry Corey: With a coronavirus vaccine on the way, clinical trials leader reflects on what’s next
Dr. Larry Corey underscored the benefit of COVID vaccines.
Questions remain about whether cancer patients should get vaccine
Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.
Countdown to a Coronavirus Vaccine
The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.
CDC release revised guidance for quarantine length
Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.
Many Trial Volunteers Got Placebo Vaccines. Do They Now Deserve the Real Ones?
Dr. Holly Janes discussed biostatistical implications of having placebo-treated volunteers offered the vaccine.
Fred Hutch virologist on Moderna ask for emergency vaccine use
Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
We don't know if the coronavirus vaccines can stop the virus from spreading, but top scientists are pitching a new trial that could figure that out
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Evidence Builds That an Early Mutation Made the Pandemic Harder to Stop
Dr. Trevor Bedford confirmed his assessment that scientific evidence shows the 614G variant of SARS-CoV-2 is more easily transmitted.
Make the necessary sacrifices to avoid an unimaginable catastrophe
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
How Many Americans Are About to Die?
Dr. Trevor Bedford predicted that U.S. COVID-19 deaths could reach 2,000 a day within weeks, and that “Importantly, this doesn’t assume any further increases in circulation and is essentially ‘baked into’ currently reported cases.”
The Race for a Coronavirus Vaccine Runs Through Fred Hutch
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
MLS Cup playoffs begin as COVID-19 cases spike: Will postseason be finished safely outside a bubble?
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Covid complicates Thanksgiving as families struggle to modify 2020 holiday plans
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Why It’s a Big Deal If the First Covid Vaccine Is ‘Genetic’
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
How to sign up for Seattle-area COVID vaccine trials
Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.
Roll up your sleeve to fight COVID-19: 3 new vaccine trials will start soon in the Seattle area
Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area.
Health workers worried about Halloween COVID-19 increases
Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.
Cancer researchers cross over to COVID-19 clinical trials
Dr. Josh Hill discussed treating immune responses in COVID-19 patients.
Fred Hutch opens COVID-19 Clinical Research Center
Fred Hutchinson Cancer Research Center Research announced Monday that it has opened its COVID-19 Clinical Research Center.
Against Covid-19, imperfect measures do the most good
In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.
Fred Hutch seeks increased diversity among volunteers for COVID-19 study
Dr. Alpana Waghmare described why Fred Hutch's CovidWatch study is now available for Spanish-speaking volunteers.
Three scientists race to track deadly pathogen in their city
Dr. Trevor Bedford reflected on discovering the first case of community transmission in the region in this comic feature.
Colds Nearly Vanished Under Lockdown. Now They’re Coming Back
Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.
A look back at the first death from COVID-19 in the U.S
Dr. Trevor Bedford spoke about the early cases of COVID in the U.S.
VIDEO: Quickest way to reduce COVID-19 numbers
Dr. Daniel Reeves described how increased masking is the key to lowering COVID-19 transmissions.
New ads encourage minorities to participate in vaccine trials
Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards.
New ads encourage minorities to roll up their sleeves and participate in coronavirus vaccine trials
Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.
How can you tell if a COVID-19 vaccine is working?
In an FAQ about vaccine trial statistics, Holly Janes explained how the COVID-19 trials are based on how many cases of the disease.
Why volunteer for a vaccine study? Duty, love and a willingness to experiment, participants say
Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.
Fortune 40 under 40 - Trevor Bedford
Dr. Trevor Bedford was selected for Fortune’s 40 under 40 in the healthcare category.
When school buildings reopen, start with elementaries, Bellevue-based institute says
Dr. Dobromir Dimitrov provided outside commentary on a new model focused on safely reopening schools.
One Meeting in Boston Seeded Tens of Thousands of Infections, Study Finds
Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.
Editing out herpes
Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.
‘Warp Speed’ COVID-19 Vaccine Efforts Aim for Diverse Volunteers and Long-Lasting Protection
Peter Gilbert discussed vaccine clinical trial design in a story about national efforts to rapidly find a safe and effective vaccine.
Researchers Report Covid-19 Reinfection in Hong Kong
Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.
Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking
Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.
Fred Hutch study: Here’s what it would take to reopen schools safely during the pandemic
Fred Hutch scientists described their new analysis on safely reopening schools.
How to participate In a vaccine trial
Dr. Elizabeth Halloran discussed the design of vaccine clinical trials and shared information on how people can register as a volunteer..
How to decide if you should get tested for Covid-19 before seeing friends and family
Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.
Immunology institute founded by Paul Allen shifts focus to tackle coronavirus
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire.
How ‘super spreader’ events can fuel coronavirus transmission -
Dr. Josh Schiffer described how to prevent COVID-19 superspreader events
Why Herd Immunity Won't Save Us
Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.
MLS will resume the regular season: What we know and what we don't
Dr. Steve Pergam raised concerns over MLS matches resuming.
Why the Coronavirus is More Likely to ‘Superspread’ Than the Flu
Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.
America’s obesity epidemic threatens effectiveness of any COVID vaccine
Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.
2020 flu shot strategy: Get yours early in the season
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen
Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.
Q&A: Millions of volunteers needed for COVID-19 vaccine trials
Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more.
Fred Hutchinson doctor overseeing all COVID-19 vaccine trials in phase 3
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
COVID-19 vaccine trials: What older volunteers need to know
Michele Andrasik spoke about the priorities of CoVPN and the COVID-19 vaccine trials.
The color of COVID: Will vaccine trials reflect America’s diversity?
Stephaun Wallace spoke about the barriers to clinical trial enrollment in Black, Latino and other minority populations, and the strategies to encourage those populations to participate in clinical trials.
Virus vaccine put to final test in thousands of volunteers
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
A trial for coronavirus vaccine researchers: Making sure black and Hispanic communities are included in studies
Michele Andrasik discussed how outreach methods may need to differ depending on the communities that researchers are trying to reach with COVID-19 trials.
Without a vaccine, researchers say, herd immunity may never be achieved
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
On eve of first big coronavirus vaccine study, trial leaders brace for 'unprecedented' task
Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development.
The U.S. now has 4 million cases of coronavirus. As numbers continue to rise, what can be done now?
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
How a group of Seattle scientists revealed COVID-19′s stateside spread
Trevor Bedford’s work and comments on COVID-19 from the beginning of the pandemic are referenced.
Want to sign up for a COVID-19 vaccine trial? Here’s what to know
Stephaun Wallace discussed the details of the CoVPN clinical trials and the focuses of the program.
Inside the global quest to trace the origins of COVID-19—and predict where it will go next
Trevor Bedford discussed his work with Nextstrain and the start of tracking COVID-19 in Seattle.
Coronavirus antibody study will gauge prevalence of COVID-19 in Washington state
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
UK coronavirus vaccine prompts immune response in early test
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
Over 100,000 people volunteered for COVID-19 vaccine trial in less than two weeks
Forbes covered the CoVPN program, its goals and how the network will be run.
Researchers recruit volunteers for COVID-19 vaccine trials
Stephaun Wallace provided information about the CoVPN network, specifically the call for diverse applicants across ethnic, racial, occupational groups and ages.
Help wanted: Volunteers for COVID vaccine trials
Dr. Jim Kublin explained the CoVPN network, and the goals of the program.
'You can beat the pandemic.' Former front-line workers share tips for coping with the COVID-19 surge
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Moderna’s COVID-19 vaccine moves to bigger study
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Joel McHale and Ken Jeong look for light in the darkest timeline
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Decades of research on an HIV vaccine boosts the bid for one against coronavirus
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
Rate of new COVID-19 cases in Washington now exceeds March peak
Research from Fred Hutch indicating the COVID-19 infection rate in Washington is increasing above peak levels from March is referenced.
More young people are getting — and spreading — the coronavirus
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
Fred Hutch to lead COVID-19 vaccine trials
The CoVPN announcement is covered by KING 5.
Everett Firefighters partner with Fred Hutch to research COVID-19's impact on frontline workers
Julie Czartoski explained the goals of the COVID cohort study and the value of enrolling first responders like firefighters.
Everett firefighters joining Fred Hutch COVID-19 study
Julie Czartoski discussed testing the Everett’ Fire Station as part of the COVID cohort study.
First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'
Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.
Meet the doctor democratizing COVID-19 data on Twitter
Trevor Bedford discussed his work on SARS-CoV-2 genomic epidemiology using twitter for science outreach and communications.
Drugmakers will need to test their coronavirus vaccines in tens of thousands of people to see how well they work
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
Fred Hutch to coordinate large-scale vaccine trials for COVID-19 Prevention Network
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
COVID-19 vaccine trials now open to volunteers in U.S.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Volunteers can now sign up for large coronavirus vaccine studies
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
Here's how to volunteer for a COVID-19 vaccine trial
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
The sports restart has a plan for everything—except a coronavirus outbreak
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.
In early February, the coronavirus was moving through New York
Trevor Bedford weighed in on new findings suggesting COVID-19 was spreading in New York City in early February.
a16z Podcast: Preventing pandemics with genomic epidemiology
Trevor Bedford explained how Nextstrain and genomic epidemiology can inform public health and discussed the COVID-19 pandemic.
Public health officials do a reality check on Elon Musk’s tweets about COVID-19 tests
Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives.
Fred Hutch studies immune response to COVID-19, needs participants
Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus.
Treating cancer patients with COVID-19: A New York City experience
Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection.
CDC acknowledges true coronavirus count is likely 10 times higher than official count
Elizabeth Halloran commented on the lack of clarity in COVID-19 infection case counts, suggesting the total number is much higher than current estimates.
Will Trump’s ‘Operation Warp Speed’ rush the science of a coronavirus vaccine?
Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program.
How the virus won
The New York Times recapped the COVID-19 pandemic, referencing Trevor Bedford’s work tracking the virus through Nextstrain and the Seattle Flu Study.
Early data show no uptick in COVID-19 transmission from protests
Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates.
Seattle researcher advocates early COVID-19 testing and treatment
Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered.
COVID-19 must be treated earlier to save lives, scientists advise
A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis.
Researchers want to pick up the pace on early testing and treatment for COVID-19
Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed.
COVID-19 transmission in Seattle region rises back above key threshold, new estimates show
Data on COVID-19 infection rates from Fred Hutch, suggesting the infection rate in Washington State has risen, is referenced.
The enormous risks and stakes driving the NBA's safety discussions
Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19.
Insurance status linked to survival benefit in cancer treatment trials
Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed.
As pressure for vaccine builds, regulators may face difficult decision
Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved.
Searching for coronavirus clues in single cells
Yuan Tian explained how inflammation factors into COVID-19, and the need for further studies on immune cells.
A coronavirus vaccine in 2020? Maybe. Here’s what has to go right
Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development.
‘Flying blind’: Doctors race to understand what Covid-19 means for people with HIV
Fred Hutch is mentioned for involvement in an HIV and COVID-19 study team, to determine if patients with HIV are at higher risk of more severe infection.
Coronavirus vaccine candidates’ pivotal U.S. testing to start this summer
Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured.
'Protest is a profound public health intervention': Why so many doctors are supporting protests in the middle of the COVID-19 pandemic
Trevor Bedford’s tweets on COVID-19 and protesting are referenced.
Researchers gauge the effect of protests and reopenings on reviving the pandemic
Trevor Bedford’s estimates of COVID-19 infections resulting from protests are referenced.
A delicate balance: Weighing protest against the risks of the coronavirus
Trevor Bedford’s tweets on estimates of COVID-19 infection rates after protests in the U.S. are referenced.
Everything will have to go 'perfectly' to have coronavirus vaccine by January, experts say
Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries.
Vaccine veterans preview milestones on the long road to the end of the pandemic
A Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire.
How and why social distancing works
Laura Matarajt explained how and why physical distancing works to help prevent the spread of COVID-19.
Amazon is really interested in the blood of COVID-19 patients
Medium referenced the CovidWatch program as part of Amazon’s role in COVID-19 response.
Some people may have an immunological 'head start' against new coronavirus, even if they've never been exposed, new research finds
Yuan Tian discussed the value that further research on T-cell responses in people with severe and mild COVID-19 infection could provide, in light of an outside study showing immune response in those without exposure.
Airlines say it’s safe to travel. But is it?
Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low.
A conversation with Trevor Bedford, the Fred Hutch scientist who became a leading voice of the coronavirus pandemic
Trevor Bedford discussed his COVID-19 research, the test, trace, isolate strategy and next steps to reopen.
Large-scale survey of Seattle-area kids shows 1% had antibodies to the coronavirus
Jesse Bloom and colleagues explained results of a recent study showing 1% of children tested had COVID-19 antibodies, about at the same rate as adults.
Virus ignited in U.S. no earlier than mid-January, study says
Trevor Bedford commented on the possibility of COVID-19 infection in early January, suggesting it was likely flu.
Researchers revise their timeline for the coronavirus’ rise in Washington state
Trevor Bedford is quoted on an updated analysis suggesting the WA1 COVID-19 patient was not the initial start to the outbreak in Washington.
Coronavirus contact tracing apps are coming to your phone. Here's how they work.
Allison Black explained COVID-19 contact tracing apps, and how they can be leveraged to slow COVID-19 spread.
New research suggests nation's first COVID-19 case was not the source of Washington's outbreak
Louise Moncla discussed new research suggesting a second introduction of COVID-19 led to the outbreak in Washington.
Coronavirus epidemics began later than believed, study concludes
Trevor Bedford discussed his updated analysis suggesting the COVID-19 outbreak began in Seattle in February.
Genetic analysis raises more questions about the history of Washington state’s coronavirus outbreak
Trevor Bedford’s analysis of COVID-19 genomes suggesting Washington’s outbreak came from an alternative source than the original patient is referenced.
New research rewrites history of when COVID-19 arrived in U.S. — and points to missed chances to stop it
Trevor Bedford’s tweets on the start of the COVID-19 outbreak in Washington and patient WA1 are discussed.
Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Is the coronavirus mutating? Yes. But here’s why you don’t need to panic
Louise Moncla commented on mutations in SARS-CoV-2 and the lack of knowledge around the impact they have on the virus.
Fred Hutch president on response to coronavirus pandemic
President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs.
Explainer: what do we now know about COVID-19 – and can you get it twice?
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
Seattle researchers part of accelerated coronavirus vaccine testing program
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
COVID-19 contact tracing apps are coming to a phone near you. How will we know whether they work?
Allison Black weighed in on COVID-19 contact tracing apps and the features they need to be effective.
Pandemic science speeds up — but there are limits
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
HIV vaccine trials group steps up to the COVID-19 plate
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
What computer-based models can tell us about coronavirus — and what they can’t
Dr. Elizabeth Halloran explained how we can use COVID-19 models to our advantage, and her recent modeling work and some of the caveats of model predictions.
No, we’re not all in this together — look at what’s happening with coronavirus in Yakima
Trevor Bedford is quoted on the lack of full COVID-19 suppression in the U.S. and the implications on further physical distancing policies.
Webby Awards: Tom Hanks, 'Game of Thrones,' Cardi B, LeBron James among winners
Trevor Bedford is listed for receiving a Webby Special Achievement award for Nextstrain.
Amazon wants to innovate its way out of the pandemic
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Coronavirus investigated: Scaling vaccines
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Bowman: Federal bureaucrats continue to ravage Washington’s coronavirus response
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
The coronavirus is most infectious before people even know they have it, UW virologist says
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
California locked down early and took the coronavirus seriously. Why are its cases still rising?
Trevor Bedford’s comments on the COVID-19 status and lack of viral suppression in the U.S. are referenced.
Fred Hutch study targets front-line workers most at risk from the coronavirus
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
When did the coronavirus arrive in the U.S.? Here’s a review of the evidence
Dr. Trevor Bedford weighed in on when COVID-19 arrived in the U.S., the origins of the virus, and more.
A conversation about COVID-19 with biostatisticians and epidemiologists
Dr. Elizabeth Halloran discussed COVID-19 testing, strategy, and modeling with other biostatisticians and epidemiologists studying the virus.
Is there a safe way to throw socially distanced shows?
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
The genetic evolutionary tree of the U.S COVID outbreak
Trevor Bedford’s genomic analysis exploring the spread of COVID-19 across the U.S. is highlighted, along with Nextstrain.
Fred Hutch recruits essential workers for COVID-19 study
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
Coronavirus-tracking project backed by Bill Gates is put on hold due to FDA concerns
The SCAN program is explored, specifically it’s challenges and goals to track COVID-19 spread.
Coronavirus vaccine strategy: Larry Corey on the Long Run
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
Bill Gates is funding an at-home coronavirus test program — and it's already testing 300 people per day
The SCAN Initiative and the role of Gates Ventures in the program are discussed.
To take on the coronavirus, U.S. vaccine makers consider an unprecedented strategy: working together
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
NIH Director Francis Collins shares his best-case scenario for a coronavirus vaccine: We could have a shot by fall but mass-producing it will be 'a heck of a stretch' by the end of the year.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
Scanning for answers to a pandemic
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
Bill Gates is funding a new at-home COVID-19 testing program and it's already testing 300 people a day
The SCAN initiative and Gates Notes article on the program are discussed.
Let’s say there’s a COVID-19 vaccine—Who gets it first?
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
14 percent of American adults would refuse coronavirus vaccine, poll finds
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Fauci and other experts outline COVID-19 vaccine strategy
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
Bank of America gives $500,000 to Fred Hutch and Seattle Cancer Care Alliance for COVID-19 relief
GeekWire highlighted a Bank of America grant that will fund Fred Hutch COVID-19 response and the purchase of medical supplies for SCCA.
Disease experts declare it’s time to join forces for multiple COVID-19 vaccines
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
Essential workers asked to volunteer for coronavirus study
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Bill Gates has regrets
Trevor Bedford’s discovery of COVID-19 community spread through the Seattle Flu Study is referenced.
Anthony Fauci, NIH director Collins say we’ll likely need more than one coronavirus vaccine to end pandemic
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
What happens if a contact tracer contacts you?
Allison Black is mentioned for a segment where she discussed COVID-19 tracking and her work in the Bedford lab.
Big decline in Wash. State coronavirus cases after 'stay home' orders
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
The virus is constantly mutating. What that means for treating COVID-19 is up for debate
Bloomberg quoted Trevor Bedford on statements suggesting that further research is needed to determine if one COVID-19 strain is more transmissible than others.
The porn industry tests and traces. Could it offer a model for reopening amid COVID-19?
Dr. Elizabeth Halloran explained how easily accessible and repeated testing, contract tracing and isolation when sick could keep COVID-19 under control without a vaccine.
You’ll probably never know if you had the coronavirus in January
Trevor Bedford weighed in on serology testing, the true COVID-19 incidence in the U.S., and how we could use blood samples to retroactively test for COVID-19.
The US is reopening too soon. One chart shows cases are still on the rise outside the tristate area.
Dr. Elizabeth Halloran discussed the need for increased COVID-19 testing and contact tracing to justify loosening physical distancing measures
Mutations in the coronavirus spike protein
Trevor Bedford’s statements on the implications of a mutation in SARS-Cov-2’s spike proteins are referenced.
Amazon lends its expertise — and its cash — to COVID-19 research
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
Why fully recovering from coronavirus might take longer than expected
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
A mutated coronavirus strain seems responsible for most of the world's COVID-19 infections. That doesn't mean it's more dangerous than the original
Business Insider discussed Nextstrain work and Trevor Bedford’s comments on COVID-19 lineages and the unknown impact on transmissibility.
Studies of coronavirus evolution stir up a controversy for scientists on social media
Trevor Bedford’s commentary on a COVID-19 spike mutation is referenced, suggesting we don’t know the impact of the mutation on transmissibility.
So many people are convinced that they had COVID-19 already
Trevor Bedford stated that it’s not possible SARS-CoV-2 was circulating in the U.S. in or before November 2019.
Researchers find new coronavirus strain 'more contagious', potentially impacting COVID-19 vaccine search
Trevor Bedford’s statements on the impacts of a SARS-Cov-2 mutation are cited, saying we need further research to determine if it impacts transmissibility.
Coronavirus in the U.S.: an unrelenting crush of cases and deaths
Trevor Bedford’s statements predicting continued COVID-19 infections across the U.S. are cited.
What COVID-19 antibody tests can and cannot tell us
Trevor Bedford’s commentary on the lack of accuracy of some COVID-19 antibody tests is included.
The search is on for America’s earliest coronavirus deaths
Louise Moncla provided insight to why there are likely unknown early February COVID-19 deaths.
How early COVID-19 detection sounded ‘tornado siren’ for WA response
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
Was the new coronavirus accidentally released from a Wuhan lab? It’s doubtful.
Trevor Bedford reinforced the scientific reasons why COVID-19 did not originate from a lab, but rather a natural setting.
How coronavirus mutates and spreads
Trevor Bedford is listed as a source of COVID-19 spread and tracking data.
Labs across U.S. join federal initiative to study coronavirus genome
Pavitra Roychoudhury discussed her work with COVID-19 genomics and tracking, specifically a sequence sharing project.
One in 8 Americans say they know someone who died of COVID-19, according to a new Insider poll
Dr. Elizabeth Halloran commented on the potential outcomes of easing physical distancing restrictions too early.
Gilead, without details, says COVID-19 drug clears crucial clinical test
Dr. Elizabeth Duke explained issues trying to find a drug to properly control and treat COVID-19.
South Africa's HIV failures cost more than 300,000 lives. Now this painful past is helping in COVID-19 fight.
Dr. Larry Corey weighed in on the use of HIV ARV’s as potential treatments for COVID-19.
COVID-19 was here earlier than most Americans thought. Now what?
Trevor Bedford’s analysis that COVID-19 was introduced to the US sometime in January is referenced.
Top Seattle-area health official worries COVID-19 could spread across country as states reopen
GeekWire highlighted Trevor Bedford’s research tracking COVID-19, and referenced a webinar featuring Dr. Elizabeth Halloran.
The AIDS crisis forged a generation of activists; now they’re supporting the LGBTQ+ community in the coronavirus pandemic
Russell Campbell commented on how the COVID-19 pandemic echoes the AIDs epidemic in its impact on minorities and under-served populations.
Scott Gottlieb discusses coronavirus on "Face the Nation,"
Trevor Bedford’s timeline of the COVID-19 pandemic in the U.S. beginning in early January is referenced.
White House medic Deborah Birx said coronavirus deaths will 'dramatically' decrease by the end of May, but social distancing will go on for much longer
Dr. Elizabeth Halloran suggested what may happen as a result of relaxing physical distancing measures too early.
New York's low coronavirus transmission rate suggests the state's outbreak is contained for now
Dr. Elizabeth Halloran gave insight to what may happen is physical distancing measures are loosened.
Who to follow on Twitter for legit, trustworthy coronavirus info
Trevor Bedford is included as a credible source of COVID-19 information.
The real problem with the manufactured coronavirus liberty protests
Trevor Bedford is quoted on his test, trace, isolate strategies to stop the COVID-19 pandemic.
Why experts are questioning two hyped antibody studies in coronavirus hotspots
Trevor Bedford’s comments on new antibody study results suggesting high antibody prevalence in the community are included.
The coronavirus isn’t just the flu, bro
Trevor Bedford’s analysis of the death rate from COVID-19 in New York City is referenced.
Yes, the coronavirus mutates. But those tiny changes haven't affected how dangerous it is — instead, they help scientists track its spread.
Trevor Bedford’s and Nextstrain collaborator Emma Hodcraft’s comments on the mutation rate of COVID-19 and the implications of that for vaccine efficacy are discussed.
Italy's lockdowns prevented 200,000 hospitalizations and reduced coronavirus transmission by nearly half, a new study finds
Dr. Elizabeth Halloran discussed how COVID-19 differs from other infectious diseases like measles, specifically in its higher transmissibility.
A woman who recovered from the coronavirus tried to donate her plasma, but she barely had any antibodies. It highlights lingering questions about immunity.
Dr. Elizabeth Halloran suggested that while we hope being infected with COVID-19 produces immunity for at least a year, further research is needed to confirm.
The race to make vaccines faster
Andy McGuire commented on the vaccine development process in reference to COVID-19 vaccine research.
Hidden outbreaks spread through U.S. cities far earlier than Americans knew, estimates say
Trevor Bedford’s statements suggesting undetected COVID-19 spread across Washington in late February are cited.
'Expert Twitter' only goes so far. Bring back blogs
Wired discussed Trevor Bedford’s rise to Twitter fame through his research communications in a larger piece on Twitter as a news source.
A coronavirus death in early February was ‘probably the tip of an iceberg’
The New York Times referenced Trevor Bedford’s genetic analysis work placing the start of the COVID-19 outbreak in Washington in early February, in light of new data on an early February COVID-19 death.
Some Americans are convinced they had the coronavirus in December or January. Experts say it's highly unlikely.
Trevor Bedford’s tweets reinforcing that COVID-19 was not circulating in the U.S. in December are cited.
New York's subway may have boosted the coronavirus' spread, but researchers think one-third of coronavirus transmission happens in the home
Dr. Elizabeth Halloran commented on physical distancing measures in Washington, and the impact it had on slowing COVID-19 transmission.
Solving the mysteries of coronavirus with genetic fingerprints
The New York Times recalled the story of the Washington COVID-19 outbreak and how genomic analysis helped track the virus, quoting Pavitra Roychoudhury and Trevor Bedford.
CDC: First US coronavirus deaths happened weeks before first death in Kirkland
Louise Moncla explained why we need to expand COVID-19 tracing and testing abilities to interpret the spread that led to early deaths in California.
STAT Health Tech newsletter
STAT News highlighted a Fred Hutch and AWS collaboration on a COVID-19 study called COVIDWatch
Mutations map holds the key to bringing coronavirus under control
Trevor Bedford’s statements on when COVID-19 began circulating in the U.S. and Nextstrain findings are referenced.
UPDATED: Datavant boots up a big COVID-19 registry — looking to shine a light on virus spread, impact and most effective therapies
Dr. Joshua Schiffer commented on a new COVID-19 patient registry to improve research efforts.
COVID-19 Q&A with experts
Dr. Joshua Schiffer is quoted on the use of hydroxychloroquine for COVID-19 treatment and the lack of understanding of its impact.
To know the real number of coronavirus cases in the US, China, or Italy, researchers say multiply by 10
Dr. Elizabeth Halloran emphasized the difficulty in determining to number of COVID-19 cases due to lack of testing.
What viral evolution can teach us about the coronavirus pandemic
Trevor Bedford’s work is referenced as part of an analysis of how we study pandemics and disease.
Saving a city: How Seattle’s corporate giants banded together to flatten the curve
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
A New York City hospital developed one of the few FDA-approved antibody tests for the coronavirus. It could test up to 2,000 people per day
Dr. Elizabeth Halloran explained that COVID-19 serological tests have not yet been perfected, and some may give false results.
Risky business: Scientists seek volunteers for ‘CovidWatch’ virus-tracking study
GeekWire covered a new Fred Hutch study, Covidwatch, focused on those most at risk to get COVID-19, to help us better understand characteristics of the virus.
Seattle researchers report early results from first US ‘swab and send’ COVID-19 surveillance program
Early results from the SCAN program, of which Fred Hutch is a partner, are discussed.
Chris Cuomo says his one coronavirus 'silver lining' just came crashing down
Trevor Bedford’s statements reinforcing COVID-19 was not in the U.S. last fall are referenced.
Greater Seattle coronavirus assessment network (SCAN) releases data from first 18 days of testing
Dr. Tom Lynch commented on the hard work and early data from the SCAN COVID-19 testing program.
How coronavirus testing and contact tracing work together to quell COVID-19
Trevor Bedford’s tweets explaining his test, trace, and isolate strategies for COVID-19 using digital and non-digital tools are discussed.
The US is 'a long way' from beating the coronavirus with herd immunity, experts say, since that would require 50% of the population being immune
Dr. Elizabeth Halloran commented on the possibility of herd immunity to COVID-19, suggesting we have not reached that level of infection.
The coronavirus is mutating. What does that mean for a vaccine?
Trevor Bedford commented on how mutation rates may or may not impact a COVID-19 vaccine.
One key figure helps countries decide when their coronavirus outbreaks are over — but scientists say it's a moving target
Dr. Elizabeth Halloran advised on the conditions necessary to lift COVID-19 lockdowns and keep the virus under control.
U.S. grapples with how to drastically ramp up COVID-19 contact tracing
Trevor Bedford’s digital tracing endeavor, Nexttrace, is cited as one way to slow COVID-19.
Another sign the curve is bending: Positive coronavirus tests at UW peaked March 28
Larry Corey provided context to a new study from Fred Hutch and UW suggesting Washington state has successfully lowered COVID-19 infections through physical distancing measures.
Avoid Twitter’s swamp of misinformation by following these epidemiology experts
Trevor Bedford is listed as a COVID-19 expert, to help reduce misinformation about the virus.
Tips on using science Twitter during COVID-19
PLoS Blogs delved into science communications, referencing Trevor Bedford’s use of twitter to explain COVID-19 research.
Genetic tracking helped us fight Ebola. Why can’t it halt COVID-19?
Trevor Bedford’s genomic analysis work to track COVID-19 from the initial outbreak in the U.S. is mentioned.
NY death toll passes 10,000; new hot spots slow to emerge
Trevor Bedford suggested even with lifted physical distancing measures, COVID-19 may not rebound as strongly as the public exercises more caution.
Coaches team up in battle against COVID-19
Fred Hutch Coaches vs. COVID fundraiser Tanner Swanson discussed why he was motivated to fundraise for Fred Hutch research.
Seattle researcher debunks theory COVID-19 spread in Calif. in November
KOMO covered Trevor Bedford’s latest tweets debunking beliefs that COVID-19 was circulating prior to January in Washington and California.
More on that alleged intel report, and when did COVID-19 really begin?
Trevor Bedford’s statements reinforcing the timeline of the U.S. COVID-19 outbreak are included, along with data from Nextstrain.
When will this end, and what comes next? Health officials and epidemiologists are working to figure out Washington’s coronavirus end game
Dr. Elizabeth Halloran and Trevor Bedford’s recommendations to keep COVID-19 at bay and loosen physical distancing measures are discussed.
Episode 8: The virus-eye view
Jesse Bloom and Harmit Malik explained the process of a viral infection, referencing SARS-CoV-2 from first introduction into the body to the onset of the infection.
No, you did not get COVID-19 in the fall of 2019
Allison Black, a genomic epidemiologist in the Bedford Lab, debunked sentiments that SARS-CoV-2 was circulating in the U.S. in fall 2019.
Can smart phone apps help beat pandemics?
Trevor Bedford’s work on NextTrace, a digital COVID-19 tracing method, is highlighted.
COVID-19 and cancer: How to protect ‘the most vulnerable’ during pandemic
Dr. Steve Pergam commented on the increased susceptibility for COVID-19 within cancer patients, and how oncologists should prepare.
Before the flood
Dr. Steve Pergam, along with other first responders in the Seattle area, published a piece on the COVID-19 pandemic and outbreaks in Washington.
Social distancing is controlling COVID-19; now scientists need to figure out which measures are most effective
Trevor Bedford’s latest tweets suggesting physical distancing measures have been effective in Washington state are cited.
Blood tests promise to show who had COVID-19 and didn’t know it
Drs. Keith Jerome and Larry Corey explained work on blood tests for CoV-2 antibodies and the need for a vaccine.
Most New York coronavirus cases came from Europe, genomes show
Trevor Bedford reinforced that his genomic analysis suggested a January introduction of COVID-19 to the U.S.
'Did I already have coronavirus?': People wonder if they previously had COVID-19, but the answer isn't easy
Trevor Bedford’s analysis suggesting a mid-January start date for the COVID-19 outbreak in Washington state is referenced.
Seattle’s COVID-19 lessons are yielding hope
Trevor Bedford’s initial research suggesting community COVID-19 transmission in Washington is recalled.
How the coronavirus overwhelmed Washington state’s early efforts to contain it
Trevor Bedford’s early analysis that COVID-19 was circulating undetected in Washington State is referenced.
Alexa, do I have coronavirus?
Trevor Bedford is referenced for his work and comments on fighting COVID-19.
How do COVID-19 deaths compare to flu deaths in Washington state?
Dr. Steve Pergam’s comments on how COVID-19 compares to the flu are included.
Infectious disease expert Steve Pergam shares his prescription for a safe weekend get-together
GeekWire covered Dr. Steve Pergam’s live COVID-19 Q&A, highlighting ways to stay safe but social.
Questions but few answers on COVID-19
Dr. Elizabeth Halloran answered questions about the outlook for COVID-19, and next steps to stop the pandemic.
Coronavirus sleuths kick off campaign for digital tracing of COVID-19 contacts
GeekWire profiled Trevor Bedford’s new program NextTrace, that uses contact-tracing to stop COVID-19.
COVID-19: What's happening now (April 1, 2020)
Dr. Gary Lyman and Dr. Michael Boeckh discussed patient care and safety during COVID-19, and the Cancer Care COVID-19 registry.
In the race to crack COVID-19, scientists bypass peer review
Undark mentioned Trevor Bedford’s use of twitter to comment on a preprint paper about COVID-19.
Genetic analysis of the coronavirus gives scientists clues about how it’s spreading
Trevor Bedford’s use of genetic data to link the COVID-19 patients in Washington is cited.
With record-setting speed, vaccine makers take their first shots at the new coronavirus
Dr. Larry Corey commented on the quick development of potential vaccines and vaccine trials for COVID-19.
Virologists are divided over need for draconian shutdowns
Trevor Bedford’s proposed strategies for slowing and tracking COVID-19 spread are considered, along with others.
The mathematics of predicting the course of the coronavirus
Wired reflected on Trevor Bedford’s analysis that by early March COVID-19 had already been circulating in Washington State for weeks.
As coronavirus spreads, Seattle scientists fast-track potential treatments for COVID-19
Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19.
One Seattle party, 8 coronavirus cases: An anatomy of an outbreak
Trevor Bedford’s analysis indicating COVID-19 community transmission had occurred in January is discussed.
Experts converge on plans for easing coronavirus restrictions safely
The Washington Post discussed a report co-written by Trevor Bedford, outlining steps to guide states through the COVID-19 outbreak.
Handicapping the future of financial markets
Trevor Bedford is included in a list of scientific resources on COVID-19.
The other coronavirus test we need
Dr. Jesse Bloom discussed the logistics of developing and using a serological test for the virus causing COVID-19, to determine who has been exposed to the virus.
The Seattle scientific community, mobilized
Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford.
Dr. Julie McElrath on lifting physical distancing measures
Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures.
How coronavirus mutations can track its spread—and disprove conspiracies
Trevor Bedford explained how Nextstrain has evolved with open and rapid data sharing, allowing for real time tracking of COVID-19 mutations and spread.
Dr. Julie McElrath on COVID-19 vaccines
Dr. Julie McElrath discussed potential COVID-19 vaccine options and programs.
The U.S. now has more confirmed coronavirus cases than anywhere else in the world
Vox mentioned Trevor Bedford’s U.S. COVID-19 infection estimates and research on the spread of the virus.
How does the coronavirus behave inside a patient?
Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19.
Eerily on the mark, a gene detective's coronavirus findings raise hope and fear in equal measure
The Nextstrain project and Trevor Bedford’s analyses on COVID-19 are explained.
The coronavirus is mutating. But that may not be a problem for humans
Trevor Bedford commented on the implications of COVID-19’s slow mutation rates, suggesting it will lead to immunity after exposure.
The coronavirus mutates more slowly than the flu — which means a vaccine will likely be effective long-term
Trevor Bedford’s comments on the mutation patterns of COVID-19 and how that impacts vaccine production are cited.
COVID-19 poses special challenges to cancer care
Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.
Fred Hutch researcher: ‘We need facts from experts’ in coronavirus briefings
Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment.
Seattle coronavirus assessment network launches with boost from Bill Gates, Amazon and volunteers
The new SCAN initiative is profiled, mentioning Fred Hutch as one of the founding partners.
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Dr. Masumi Ueda explained how Fred Hutch’s clinical care partner Seattle Cancer Care Alliance approached COVID-19 prevention and identification in clinics and workspaces.
How long will the outbreak last? It depends on what we do now
Trevor Bedford is quoted on ideas to tackle the COVID-19 pandemic through social distancing and extensive testing.
The coronavirus testing paradox
Trevor Bedford’s tweets on suggested strategies to curb the COVID-19 pandemic are quoted, specifically on the need for increased testing and social distancing.
When will the coronavirus pandemic end? What scientists can say about life returning to normal
Dr. Elizabeth Halloran reinforced the need for COVID-19 testing to control the pandemic.
How the virus got out
Trevor Bedford and Dr. Elizabeth Halloran provided expertise for this interactive COVID-19 map, which overlays travel and migration data with epidemiological data.
How the coronavirus became an American catastrophe
The Atlantic described Trevor Bedford’s work in discovering COVID-19 had spread in Washington to his recommendations for slowing the pandemic.
The 9 most important unanswered questions about COVID-19
Trevor Bedford commented on U.S. COVID-19 infection rates, providing estimates between 10,000 – 40,000.
How to navigate cancer in the wake of the COVID-19 pandemic
Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection.
Study suggests COVID-19 might follow seasonal pattern
Dr. Elizabeth Halloran provides context to COVID-19 transmission rates and spread.
How genetic mapping is allowing scientists to track the spread of coronavirus
Trevor Bedford and Jesse Bloom gave context to how they used genomic analysis of COVID-19 to track its spread.
How long will Americans be fighting the coronavirus?
Dr. Elizabeth Halloran explained community transmission and how it can lead to an epidemic in reference to COVID-19.
The danger of a second wave
Trevor Bedford’s methods for stopping the COVID-19 outbreak are outlined, including isolating the infected, and having those who are recovered return to work.
Coronavirus sleuth outlines his ‘Apollo program’ for bringing down the pandemic
Trevor Bedford commented on a new modeling report, suggesting how social distancing measures and testing can stop the COVID-19 pandemic.
Mild cases may be driving coronavirus spread
WebMD discussed Dr. Elizabeth Halloran’s Science paper on COVID-19 modeling and preventative measures to limit transmission.
How South Korea scaled coronavirus testing while the U.S. fell dangerously behind
Trevor Bedford commented on the Ohio COVID-19 infection numbers, suggesting they are overestimated.
Why social distancing is so hard – and so important
Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.
11 things everyone should know about getting the novel coronavirus
Vox mentioned Trevor Bedford’s estimates that there are around 20,000 COVID-19 cases across the U.S. to date.
Coronavirus is hiding in plain sight
Dr. Elizabeth Halloran, an infectious disease expert, provided commentary on the need for widespread COVID-19 testing.
Over 85% of COVID-19 infections in China went undetected early on
Dr. Elizabeth Halloran reinforced the importance of testing and social distancing to lower COVID-19 transmission.
COVID-19 and cancer
Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.
Why Washington state is at the center of the US coronavirus outbreak
Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed.
'Invisible enemy'
Politico referenced Trevor Bedford’s estimate that there are between 10,000 – 40,000 U.S. COVID-19 cases.
Coronavirus: Infected people without symptoms are driving epidemic’s fast spread
Dr. Elizabeth Halloran stressed the importance of wide-spread testing to slow the spread of COVID-19.
Scott Gottlieb discusses coronavirus on 'Face the Nation' March 15, 2020
Trevor Bedford’s commented on COVID-19 infection rate estimates across the U.S. are considered.
How it spreads, infects: Coronavirus impact comes into focus
The Associated Press explored if reinfection is possible, referencing research on COVID-19 mutation rates from Fred Hutch.
Can people who recover from COVID-19 become reinfected?
Snopes referenced Fred Hutch research on mutation rates of COVID-19 in relation to the possibility of reinfection.
Seattle expert estimates 20,000 novel coronavirus infections in the U.S. now
Trevor Bedford’s estimates of U.S. COVID-19 infection rates are mentioned in light of new outbreaks.
Coronavirus hot zone: Research and responses in the U.S. epicenter
Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people.
The etiquette of social distancing in the time of coronavirus, from the ‘Miss Manners’ of germs
Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19.
Trump is banning travelers from the UK to combat coronavirus. Domestic travel restrictions could come next
Trevor Bedford’s research suggesting most new COVID-19 cases are due to community transmission rather than travel is highlighted.
Flu watchdog spots more with fever and cough, but it’s not flu
Trevor Bedford’s tweets on transmission chains leading to COVID-19 outbreaks across the U.S. are mentioned.
Mapping the social network of coronavirus
Betz Halloran commented on the power of data science and modeling to track COVID-19 and other viruses.
COVID-19 can’t spread if you stay home
A modeling study from Fred Hutch is cited on results suggesting Seattle two weeks ago was approximately in the position of Wuhan, China, on Jan. 1.
Is your cancer center ready for COVID-19?
Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk.
Efforts to control coronavirus could get even more extreme
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
Microbiome predicts blood-cell transplant success
David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.
Data sharing and open source software help combat COVID-19
Open data sharing and the use of Nextstrain by Trevor Bedford and colleagues to track COVID-19 is discussed.
How much is coronavirus spreading under the radar?
Trevor Bedford’s discovery of community transmission of COVID-19 in Washington is referenced.
Cancelations and rising confusion: This week’s coronavirus news
Trevor Bedford is included in a list of COVID-19 experts.
Coronavirus is already here. Blocking travelers won’t prevent its spread.
Vox referenced Trevor Bedford’s analysis on the impact of travel bans to prevent COVID-19 spread.
Without ‘social distancing,’ 400 could die from coronavirus in Western Washington by April 7, study suggests
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
Local efforts are much more important than travel bans to stop the spread of infection
Dr. Elizabeth Halloran discussed her Science study showing how travel bans slowed but did not stop the spread of COVID-19.
Sports provide a refuge, but they blurred our vision on coronavirus
A study by Trevor Bedford and colleagues predicting infection rates is referenced in light of new social distancing measures.
Researcher says more coronavirus testing will help manage outbreak, but travel bans? Not so much
Trevor Bedford’s analysis on infection rates and the efficacy of travel bans to lower COVID-19 transmission is discussed.
Scientist links 2 state outbreaks with genetic fingerprints
Trevor Bedford explained his analysis of the transmission pathway of COVID-19 throughout Washington, likely beginning with one person.
Merkel gives Germans a hard truth about the coronavirus
Infectious disease expert Betz Halloran provided global infection rate estimates based on her research.
Please, listen to experts about the coronavirus. Then step up.
Trevor Bedford is referenced for his research suggesting a larger outbreak in Washington than testing has reflected.
AP source: Inslee to ban large gatherings in Seattle area
Trevor Bedford’s research with Seattle Flu Study is referenced as support for new social distancing measures.
“The nature of viruses is to mutate”: Mapping the spread of a deadly disease
Vanity Fair profiled Trevor Bedford and Nextstrain collaborators, referencing tracking COVID-19, genomic analysis and transmission rates.
Why older and chronically ill Americans are at greatest risk from coronavirus
Dr. Steve Pergam comments on COVID-19 risk for cancer patients.
How does one Seattle coronavirus patient turn into two six weeks later?
Massive Science delves into how COVID-19 spread without detection, referencing Trevor Bedford’s detailed genetic analysis of community transmission.
Cancer patients and coronavirus: Here's everything to know
Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19.
How to cope with Seattle’s coronavirus outbreak? Pretend that you’re snowed in
GeekWire discussed social distancing in light of Trevor Bedford’s COVID-19 transmission predictions.
Italy’s coronavirus crisis could be America’s
Trevor Bedford is quoted among other Nextstrain collaborators on their COVID-19 analysis, in light of Italy's outbreak.
Mutations can reveal how the coronavirus moves—but they’re easy to overinterpret
Trevor Bedford’s genetic analysis on the spread of COVID-19 into Italy and the spread across Washington State is considered.
Seattle’s patient zero spread coronavirus despite ebola-style lockdown
Bloomberg followed the Washington COVID-19 outbreak, including Trevor Bedford’s discovery of community transmission and subsequent genetic analysis of the spread.
Coronavirus mismanagement is risking American lives
Fred Hutch and Trevor Bedford’s modeling results suggesting undetected COVID-19 are cited in a commentary about COVID-19 spread.
Gates Foundation to deliver at-home coronavirus test kits, additional funding to Seattle
Fred Hutch is mentioned as one of the institutions supporting Seattle Flu Study.
Coronavirus: A disease that thrives on human error
Trevor Bedford is quoted on his research on missed transmission pathways of COVID-19.
The official coronavirus numbers are wrong, and everyone knows it
Trevor Bedford’s data indicating untracked COVID-19 spread in Washington State is referenced.
Study says travel restrictions can delay, but can’t defeat a global coronavirus outbreak
Biostatistician Elizabeth Halloran’s research on the role of travel restrictions in delaying COVID-19 spread is discussed.
I live in Kirkland, epicenter of the US outbreak. We need Trump to take this seriously
Fred Hutch research on COVID-19 community transmission rates in Kirkland, Washington is mentioned.
Coronavirus vs. oncology: Meeting cancellations, travel restrictions, fears about drug supply chain
The Cancer Letter includes Fred Hutch’s remote work policy in a list of updates related to COVID-19.
Fred Hutch mandates remote working to curb COVID-19
FierceBiotech profiled Fred Hutch for COVID-19 remote work policies and for Trevor Bedford’s COVID-19 research.
Some good coronavirus news: genetic detectives are on the case
Computational biologist Trevor Bedford explained how researchers are using Nextstrain and genetic analysis techniques to track COVID-19 in real time.
Seattle's critical coronavirus test
Gates Foundation funding of COVID-19 research, including Fred Hutch and Seattle Flu Study, is mentioned.
Scientists say coronavirus mutations aren’t more deadly or contagious
Computational biologist Trevor Bedford discussed how he has been using Nextstrain to understand COVID-19 genetics and spread.
The race to unravel the United States’ biggest coronavirus outbreak
Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development.
Software and genetic sequencing track the coronavirus's path
Trevor Bedford’s research using the Nextstrain platform is explored, specifically its role in real time tracking of COVID-19.
Coronavirus in the US: Tracking cases and deaths
Trevor Bedford's research suggesting under detection of COVID-19 cases in Washington State is mentioned.
Exclusive: The strongest evidence yet that America is botching coronavirus testing
Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread.
Fred Hutchinson Center initiates mandatory work-from-home policy as outbreak roils businesses, conferences
Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State.
In the age of coronavirus, our nation needs a responsible leader who trusts scientists
Trevor Bedford explains how a lack of testing allowed COVID-19 to spread undetected in Washington State.
Why Washington State? How did it start? Questions answered on the U.S. coronavirus outbreak
Trevor Bedford’s work on the spread and genetic variation of COVID-19 from China to the US is discussed.
The coronavirus is exposing another disease we need to cure, stat
A columnist referenced computational biologist Trevor Bedford and his blog content on COVID-19 projected spread and recommendations.
Response in China slowed outbreak of coronavirus — but experts caution against extreme measures in Seattle
Fred Hutch and computational biologist Trevor Bedford are referenced on the COVID-19 outbreak and preventative measures cities are taking to slow the spread of the virus.
UW Medicine gets green light to test for coronavirus
Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine.
Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing
The rapid data sharing involved in Trevor Bedford’s work is discussed as an example of open science.
Washington State risks seeing explosion in coronavirus cases without dramatic action, new analysis says
Computational biologist Trevor Bedford explained his analysis on COVID-19 spread and provided recommendations for the greater Seattle area.
What people with HIV need to know about the new coronavirus
Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19
Authorities announce 2nd coronavirus death in US
Trevor Bedford, a computational biologist, is quoted on his COVID-19 genetic analysis.
Coronavirus may have spread in Washington state for weeks, according to study
Computational biologist Trevor Bedford and his research on the Washington COVID-19 outbreak is discussed.
New coronavirus cases in Western Washington are likely doubling every 6 days, Fred Hutch scientist says
Trevor Bedford, a computational biologist, provided expert commentary on the infection rates and genetic analysis of COVID-19.
What people with cancer need to know about the new coronavirus
Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.
Genetic analysis suggests coronavirus infections double every six days, spreading to hundreds
Computational biologist Trevor Bedford discussed his analysis providing COVID-19 infection estimates for Washington state
A dire phase of the coronavirus outbreak? ‘Boom’ of US cases ‘should be expected’ as global death toll tops 3,000
Trevor Bedford, a computational biologist, is quoted on the COVID-19 spread and genetic analysis.
A second person in the U.S. – and King County – dies of novel coronavirus; more cases likely
Computational biologist Trevor Bedford is quoted on COVID-19 transmission in Seattle.
Coronavirus may have spread in U.S. for weeks, gene sequencing suggests
Computational biologist Trevor Bedford is quoted on the COVID-19 outbreak in Seattle.
As testing quickly ramps up, expect more U.S. coronavirus cases
Trevor Bedford, a computational biologist, is mentioned in reference to COVID-19 genetic analysis and spread in Washington.
Scott Gottlieb “Face the Nation”
Computational biologist Trevor Bedford and Fred Hutch are mentioned in reference to the COVID-19 outbreak and genetic analysis.
No, the coronavirus was not genetically engineered in a Wuhan lab, expert says
Trevor Bedford, a computational biologist, provided expert commentary on the origins of COVID-19.
Here’s how computer models simulate the future spread of new coronavirus
Elizabeth Halloran, an infectious disease expert, discussed modeling and projections for COVID-19’s spread.
'We're opening everything': Scientists share coronavirus data in unprecedented way to contain, treat disease
Trevor Bedford, a computational biologist, shared his thoughts on how open data sharing has aided real-time tracking of COVID-19.
Mining coronavirus genomes for clues to the outbreak’s origins
Trevor Bedford, a computational biologist, discussed COVID-19 and his research on the virus’ genome.
Robot is helping to treat man with coronavirus in special isolation room at hospital north of Seattle
Computational biologist Trevor Bedford’s research on COVID-19 is mentioned in reference to a patient in Everett, Washington.
Containing new coronavirus may not be feasible, experts say, as they warn of possible sustained global spread
Computational biologist Trevor Bedford discussed projections for the spread of COVID-19.
Scientists race to find out how Wuhan victims became ill
Trevor Bedford, a computational biologist, provided expert commentary on COVID-19.
New virus paralyzes Chinese cities
Computational biologist Trevor Bedford discussed COVID-19.
Could China's new coronavirus become a global epidemic?
Trevor Bedford, a computational biologist, discussed his analysis of COVID-19 genomes.
China coronavirus: Six questions scientists are asking
Computational biologist Trevor Bedford provided expert commentary on COVID-19.
Fred Hutchinson is researching new cancer treatments in the cloud with AWS
Dr. Raphael Gottardo discussed how machine learning can help his work in immunotherapy research.
An HIV vaccine by 2021? Here is what needs to happen
Forbes detailed the current status of HIV trials, including those conducted by the HIV Vaccine Trials Network, which is headquartered at Fred Hutch.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
HIV vaccine shows signs of cross-subtype protection
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
HIV vaccine shows signs of cross-subtype protection
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
Phase 1 study demonstrates safety of pembrolizumab in patients with HIV and advanced cancer
American Journal of Managed Care featured Dr. Tom Uldrick’s recent study showing that pembrolizumab is safe in cancer patients with HIV.
Protecting against RSV
Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering.
Genetically engineered immune cells fight off deadly virus in mice
Science covered a B cell engineering study led by Dr. Justin Taylor.
Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study
GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses.
London man seems to be free of HIV in second such case
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Vaccines don’t work against some viruses. CRISPR might one day fix that
This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV).
1st of its kind Seattle flu study aims to stop flu before it becomes pandemic
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
Seattle’s HIV Hope
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Got the flu? Seattle wants to swab your nose for a massive health data project
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
World AIDS Day
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
Majority of HIV persistence during ART due to infected cell proliferation
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
The smaller the city, the bigger the flu epidemic
Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.
Seattle scientists lead the way on HIV vaccine research
KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.
New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation
GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.
Can we gene-edit herpes away?
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Open-source project uses genetic data from viruses to help scientists track outbreaks in real time
Coverage of Open Science Prize, awarded to Drs. Trevor Bedford and Richard Neher
A new genetic tool maps how deadly viruses spread around the world in real time
Article explains a new genetic tool, Nexstrain, for which creators Drs. Trevor Bedford and Richard Neher were awarded the inaugural Open Science Prize by the National Institutes of Health, Wellcome Trust and Howard Hughes Medical Institute
Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
This ring can help stop the spread of HIV in women
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
This ring can help stop the spread of HIV in women
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
In pursuit of an HIV vaccine and the AIDS-free generation
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
Cocktails for cancer with a measure of immunotherapy
Article about the next frontier in cancer immunotherapy quotes Dr. Martin "Mac" Cheever, a cancer immunologist at Fred Hutch
Seattle scientists create blood test to predict tuberculosis
Article about a new blood test to predict whether latent tuberculosis will develop into active TB mentions that a related TB vaccine clinical trial in Cape Town, South Africa, was designed by biostatisticians at Fred Hutch